Echelon Biosciences Inc
- View government funding actions
- Salt Lake City, UT 84108
- Phone: 801-588-0455
- Corporate URL: www.echelon-inc.com
- Estimated Number of Employees: 30
- Estimated Annual Receipts: $5,475,000
- Business Start Date: 1997
- Contact Person: Kelly Sauder
- Contact Phone: 801-588-0455
- Contact Email: ksauder@echelon-inc.com
- Business Structure:
- Corporate Entity (Not Tax Exempt)
- Business Type:
- For Profit Organization
- Manufacturer of Goods
- Industries Served: All Other Basic Organic Chemical Manufacturing, Biological Product (except Diagnostic) Manufacturing, Research and Development in Biotechnology
- Product Areas: TRAILERS, MISCELLANEOUS VEHICULAR COMPONENTS, EARTH MOVING AND EXCAVATING EQUIPMENT, EARTH MOVING & EXCAVATING EQ, MISCELLANEOUS CONSTRUCTION EQUIPMENT, MISC CONTRUCT EQ, FITTINGS FOR ROPE, CABLE, AND CHAIN, ELECTRIC VEHICULAR LIGHTS AND FIXTURES, ELEC VEHICULAR LIGHTS & FIXTURES, BARS AND RODS, PLATE, SHEET, STRIP, FOIL, AND LEAF
Sampling of Federal Government Funding Actions/Set Asides
In order by amount of set aside monies.
- $430,000 - Thursday the 23rd of April 2015
National Institutes Of Health
NIH, NICHD, OD OAM OFC ADMIN MGMT
SBIR PHASE II - $1,136,508YR 1: BASE: $548,090, PARTIALLY FUNDED AT $430,000 (BALANCE TO BE FUNDED: $118,090)YR 2: OPTION: $588,418 - $118,090 - Thursday the 23rd of April 2015
National Institutes Of Health
NIH, NICHD, OD OAM OFC ADMIN MGMT
SBIR PHASE II - $1,136,508YR 1: BASE: $548,090, PARTIALLY FUNDED AT $430,000 (BALANCE TO BE FUNDED: $118,090)YR 2: OPTION: $588,418
© Copyright 2019
The Collier Report published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources.
No reliance should be made by readers or Collier Report subscribers.
Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances.
Requests for the modification of displayed information may be made to help.desk@1918.media.